Beta-D-2'-deoxy-2'alpha-fluoro-2'-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

• 收藏
• 分享

专利权人:

Inc.;Atea Pharmaceuticals

发明人:

Sommadossi, Jean-Pierre,Moussa, Adel

申请号：

AU2016229966

公开号：

AU2016229966A8

申请日:

2016.03.07

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

A compound of the structure (A), or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/